Antibiotic prescribing in patients with acute rhinosinusitis is not in agreement with European recommendations

Figures & data

Table I. Characteristics of patients included.

Country	No. of patients (%)	No. of patients with RTI (% rhinosinusitis)	No. of women (%)	Median age (iqr)	No. of patients with fever (%)	Median no. of days with symptoms (iqr)	No. of patients with < 5 days of symptoms (%)	No. of patients prescribed antibiotics (%)
Argentina	105 (9.1)	4374 (2.4)	70 (66.7)	25 (14–35)	50 (47.6)	4 (2–5)	80 (77.7)	90 (85.7)
Denmark	272 (23.7)	3904 (7.0)	187 (68.8)	41 (32–55)	83 (30.5)	7 (4–12)	104 (39.3)	203 (74.6)
Lithuania	74 (6.4)	2706 (2.7)	29 (39.2)	19 (12–35)	26 (35.1)	5 (3–7)	43 (60.6)	69 (93.2)
Russia	134 (11.7)	3685 (3.6)	77 (57.5)	24 (6–42)	49 (36.6)	3 (2–5)	108 (83.1)	81 (60.5)
Spain	445 (38.7)	16751(2.7)	277 (62.3)	36 (28–48)	150 (33.7)	5 (3–9)	227 (52.1)	388 (87.2)
Sweden	120 (10.4)	1853 (6.5)	87 (72.5)	45 (33–57)	34 (28.3)	10 (7–14)	18 (15.7)	105 (87.5)
Total	1150 (100)	33273 (3.5)	727 (63.2)	35 (25–48)	392 (34.1)	5 (3–10)	580 (51.8)	936 (81.4)

Figure 1. Antibiotic prescribing rates (%) for patients with acute rhinosinusits in six countries.